Umbilical cord blood is a rich source of hematopoietic stem cells, which are the precursor cells capable of developing into all types of blood cells, including red blood cells, white blood cells, and platelets. According to the National Marrow Donor Program (NMDP), these cells are used in transplant medicine to treat over 80 diseases, including leukemia, lymphoma, and various inherited metabolic and immune system disorders.
The Biological Function of Cord Blood Stem Cells
Cord blood is the blood that remains in the placenta and umbilical cord after a baby is born. Unlike bone marrow, which requires a surgical procedure for collection, cord blood is harvested through a non-invasive process immediately following the delivery of the infant.
The primary utility of these cells lies in their ability to reconstitute the patient’s immune and blood-forming systems. As noted by the Cleveland Clinic, hematopoietic stem cells from cord blood are more "naïve" than those found in adult bone marrow. This biological characteristic often results in a lower risk of graft-versus-host disease (GVHD), a common and potentially serious complication where the donor’s immune cells attack the recipient’s tissues.
Public vs. Private Banking Options
Parents typically choose between two primary methods for preserving cord blood: public donation or private storage.
- Public Cord Blood Banks: These facilities store donated cord blood for use by any patient in need of a match. According to the U.S. Health Resources and Services Administration (HRSA), there is no cost to the donor family for public banking. These units are listed on national registries, making them available to the general public.
- Private Cord Blood Banks: Families may opt to pay for the collection and long-term storage of their child’s cord blood for potential "directed" or "family" use. The American College of Obstetricians and Gynecologists (ACOG) advises that private storage is generally only recommended for families with a known medical history of a specific genetic condition that could be treated with a stem cell transplant.
Clinical Applications and Limitations
Transplantation remains the standard of care for cord blood use. While research into regenerative medicine—using stem cells to repair damaged tissues—continues to expand, the National Institutes of Health (NIH) emphasizes that most "off-label" or experimental uses of cord blood outside of established hematologic transplants are not currently supported by clinical evidence.
Patients considering banking should consult with their obstetrician or a hematologist to understand the statistical likelihood of needing the sample. Because the total volume of blood collected from a single umbilical cord is limited, it may not contain enough stem cells to treat a full-grown adult, which serves as a factor in clinical decision-making.
Frequently Asked Questions
Does cord blood banking interfere with the birth process?
No. Collection occurs only after the umbilical cord has been clamped and cut, ensuring no interference with the delivery of the infant.
How long can cord blood be stored?
When processed and cryopreserved according to industry standards, cord blood units can remain viable for decades. The FDA regulates these facilities to ensure the safety and quality of the stored biological products.
Is cord blood a cure for all diseases?
No. Cord blood is specifically used for blood-related conditions and immune deficiencies. It is not currently a proven treatment for conditions like cerebral palsy or autism, despite ongoing clinical trials in those areas.
Related reading